Cross Country Healthcare/$CCRN

13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX

About Cross Country Healthcare

Cross Country Healthcare Inc is a provider of total talent management services, including strategic workforce solutions, contingent staffing, permanent placement and consultative services for healthcare customers. The company operates in two business segments: the nurse and allied staffing segment, which generates a vast majority of revenue, offers temporary and permanent placements of travel and local nurses and allied professionals, and other outsourcing services.: the Physician Staffing segment provides licensed practitioners across a broad array of specialties, as well as certified registered nurse anesthetists (CRNAs), nurse practitioners (NPs), and physician assistants (PAs) on temporary assignments. The company earns majority of its revenue from the United States.

Ticker

$CCRN
Sector
Primary listing

Employees

9,605

CCRN Metrics

BasicAdvanced
$410M
-
-$0.26
0.38
-

What the Analysts think about CCRN

Analyst ratings (Buy, Hold, Sell) for Cross Country Healthcare stock.

Bulls say / Bears say

Credit loss expense was immaterial at $0.03 million in Q2 2025 versus $18.9 million a year earlier, reflecting substantially improved credit risk management and reduced counterparty exposure (SEC Filing).
Physician Staffing revenue grew 3.0% year-over-year to $49.8 million, while revenue per day filled rose 12.4% to $2,239, demonstrating strong pricing power and segment resilience (SEC Filing).
Net loss narrowed to $6.7 million (–$0.20 per share) in Q2 2025 from $16.1 million (–$0.47 per share) in Q2 2024, evidencing operational leverage and effective cost controls (SEC Filing).
Revenue from services fell 19.3% year-over-year to $274.1 million in Q2 2025, driven by volume and bill rate declines in the core Nurse and Allied Staffing segment, highlighting persistent top-line pressure (SEC Filing).
Average Nurse and Allied Staffing FTEs declined 16.4% to 7,035 in Q2 2025, with revenue per FTE per day down 7.7% to $348, underscoring ongoing challenges in staffing demand and pricing compression (SEC Filing).
The proposed merger with Aya Healthcare has been delayed by an FTC request for additional information, pushing the expected close into Q4 2025 and introducing uncertainty around strategic consolidation and synergies (SEC Filing).
Data summarised monthly by Lightyear AI. Last updated on 8 Oct 2025.

CCRN Financial Performance

Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%

CCRN Earnings Performance

Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.

Buy $CCRN

Sign up or log in to buy
Capital at risk
Market closed

Upcoming events

No upcoming events
FAQs